InvestingSatellos Announces Completed Enrollment of all Four Multiple-Ascending Dose Cohorts for the Phase 1 Clinical Trial of SAT-3247 in Healthy Volunteers by TheCompaniesFebruary 10, 20250 Share0 Facebook Twitter Google+ Pinterest Amazon reddit LinkedIn Myspace
